On 14 October 2021, the Global Laboratory Initiative and the Global Drug Initiative organise a joint workshop on access to diagnostics, treatment, and care to end TB. Please register for free under the link below. https://theunion.org/our-work/conferences/52nd-union-world-conference-on-lung-health/post-graduate-workshops-courses
TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières (MSF), has found that a new, all-oral, six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculo
Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tubercu
Hundreds of patient volunteers from four continents have enrolled in a trial that aims to find safer, shorter, and effective treatments for multidrug-resistant tuberculosis (MDR-TB), an airborne, infe